Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
287204-45-9
Purity
95%
PD180970 is a highly potent and ATP-competitive p210Bcr-Abl kinase inhibitor for inhibiting the autophosphorylation of p210Bcr-Abl. It indcues apoptosis of K562 leukemic cells, and can be used for chronic myelogenous leukemia research.
Properties
Name
PD180970
Smiles
CC=1C=C(NC=2N=CC=3C=C(C=4C(Cl)=CC=CC4Cl)C(=O)N(C)C3N2)C=CC1F
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
PD 180970
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$59
2 mg
$63
5 mg
$68
10 mg
$86
15 mg
$95
20 mg
$103
25 mg
$115
30 mg
$124
35 mg
$132
40 mg
$149
45 mg
$159
50 mg
$173
75 mg
$245
100 mg
$POA
Quantity
1
Total amount
$ 68
PD 180970
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.